A fundamental tenet in pediatric health, explaining the characteristic pattern of body mass index (BMI) changes in children, is being re-examined with findings that suggest a long-held theory may be based on a misinterpretation of physiological processes. For over four decades, the prevailing scientific understanding has been that a child’s BMI, after an initial rise in infancy, typically declines before commencing a steady ascent around the age of six. This phenomenon, termed "adiposity rebound," was historically attributed to a decrease and subsequent resurgence in body fat accumulation. However, recent extensive analysis, presented at the European Congress on Obesity in Istanbul and published in The Journal of Nutrition, posits that this later increase in BMI may not, in fact, reflect a "rebound" of adipose tissue. Instead, researchers propose it is more likely an indicator of the natural, healthy development of muscle and other lean body mass.
The implications of this revised perspective are substantial, potentially altering the landscape of childhood health monitoring and intervention strategies. The original adiposity rebound theory, introduced in 1984 by French researcher Marie Françoise Rolland-Cachera and her colleagues, established a framework that influenced clinical practice. Pediatricians and other healthcare professionals have, in many instances, interpreted the timing of this BMI increase as a critical warning signal, prompting interventions aimed at mitigating potential future obesity. An early rebound, typically defined as occurring before 5.5 years of age, was linked in earlier studies to a greater likelihood of higher adiposity levels in adolescence compared to a rebound observed after seven years of age. This association, supported by statistical models, suggested that an earlier commencement of BMI rise could predispose children to higher BMI later in life.
The typical trajectory of BMI in childhood has been well-documented. Following a rapid increase during infancy, BMI reaches a peak around the first year of life. Subsequently, it undergoes a gradual decline, reaching its nadir approximately at age four, before initiating a consistent upward trend. By the age of six, a child’s BMI often returns to levels comparable to those recorded at two years of age. This predictable pattern across the pediatric population led to the conceptualization of the "adiposity rebound." The focus of extensive research has often been on the temporal aspects of this decline and subsequent rise, with the underlying assumption that an earlier upward shift in BMI signaled an increased risk of developing obesity in later childhood and adolescence.
Professor Andrew Agbaje, a physician and associate professor of clinical epidemiology and child health at the University of Eastern Finland, spearheaded the research challenging this established paradigm. Professor Agbaje argues that the observed BMI pattern should not be equated with significant biological transitions such as puberty. While puberty is a universal biological event with well-understood health implications, and precocious puberty is demonstrably linked to health risks through established biological mechanisms, Agbaje asserts that there is no comparable biological evidence to substantiate the claim that an early adiposity rebound directly causes later obesity. He emphasizes that puberty represents a profound systemic alteration of the body, whereas adiposity rebound, if it were indeed a distinct biological event, lacks such a foundational impact. Instead, he characterizes it as a natural growth process, irrespective of its timing, and contends that previous associations linking early BMI rebound to later obesity are the result of misleading statistical analyses where positive correlations do not necessarily imply biological causality.
Further bolstering the argument against the traditional adiposity rebound theory are the outcomes of long-term clinical trials designed to influence this supposed rebound. Agbaje points to these studies as evidence that the pattern is an intrinsic component of normal growth rather than a pathological process requiring intervention. One such randomized controlled trial conducted in Finland meticulously tracked participants from seven months of age through to twenty years. In this study, infants in the intervention group were introduced to a heart-healthy diet characterized by reduced saturated fat and cholesterol intake, accompanied by comprehensive dietary counseling and nutrition education for both parents and children, extending from infancy into early adulthood. The control group did not receive this intervention. Despite the prolonged and intensive nutritional program, researchers observed no discernible difference in the average age at which BMI began to decline and subsequently rise again around the age of six between the intervention and control groups. This outcome, Agbaje suggests, demonstrates that clinical trials have been unable to alter this so-called "adiposity rebound," underscoring its nature as an integral aspect of normal development rather than a disease state.
To definitively ascertain whether body fat truly undergoes a "rebound," Agbaje’s team investigated a measurement that offers a more direct assessment of adiposity than BMI. BMI, calculated from weight and height, has a significant limitation: it cannot differentiate between various body tissues, including fat, muscle, and bone. Consequently, an increase in BMI can occur due to the accumulation of healthy muscle mass, rather than solely from an increase in excess body fat. The present study employed the waist circumference-to-height ratio (WHtR), a metric recognized for its substantial accuracy in estimating body fat and adiposity, achieving approximately 90% concordance with dual-energy X-ray absorptiometry (DXA), which is considered a gold standard for measuring fat mass.
The analysis incorporated data from 2,410 multiracial children and adolescents, aged between two and nineteen years, who participated in the US National Health and Nutrition Examination Survey (NHANES) during the 2021-2023 cycle. This comprehensive dataset allowed for a comparative examination of childhood patterns in both BMI and WHtR. The average BMI at age two years was recorded as 17.1 kg/m². Following a significant decline between the ages of two and six, the BMI, on average, returned to this initial level by age six. While this specific observation, in isolation, might appear to support the traditional adiposity rebound theory, the WHtR data presented a markedly different narrative.
The average WHtR at age two years was 0.54. Crucially, children did not return to this specific WHtR level at age six, nor at any other juncture throughout their childhood and adolescent years. The WHtR consistently decreased until approximately seven years of age, after which it began to rise through the remainder of childhood and into late adolescence. However, this increase never resulted in WHtR levels that recovered to those recorded at age two. This divergence in findings, according to Professor Agbaje, indicates the absence of a genuine rebound in body fat mass. He posits that the observed increase in BMI between approximately five and seven years of age is more accurately attributed to the physiological growth of muscle and other lean tissues. Agbaje elaborates that children essentially undergo a recalibration of their body composition around the plateau observed at age four, which prepares them for subsequent growth phases.
Professor Agbaje characterizes the adiposity rebound theory as a "false discovery" driven by BMI data. He draws a parallel to the "obesity paradox," a phenomenon observed in some adult studies where individuals with obesity, under specific circumstances, have been found to exhibit lower mortality rates than those within the normal BMI range. In studies investigating heart failure and mortality, BMI has sometimes displayed a U-shaped pattern, suggesting that a higher BMI might offer protection against heart disease. Subsequent research has indicated that this apparent protective effect may stem from greater muscle mass rather than excess body fat, as BMI includes muscle mass in its overall weight calculation, potentially leading to misleading associations. In contrast, when WHtR was analyzed in randomized clinical trials concerning heart failure, a linear relationship was consistently observed, with greater fat mass invariably associated with poorer cardiovascular outcomes. This, Agbaje argues, renders WHtR a more robust tool than BMI for identifying excess fat and its associated health risks.
The research team unequivocally labels the adiposity rebound concept a "BMI fallacy," advocating for its discontinuation in pediatric literature. They assert that it does not represent a genuine disease state or a critical period necessitating clinical intervention, but rather a statistical anomaly. The growth of fat-free mass, or lean mass, is presented as the accurate physiological explanation for the body composition adjustments occurring in early childhood. This phenomenon, they argue, is a natural survival mechanism that has been erroneously interpreted as a pathological process for the past 42 years, leading to misguided efforts in treatment and prevention. Therefore, the term "adiposity rebound" is deemed inaccurate, signifying a misinterpretation of muscle mass accumulation.
Agbaje anticipates that these findings will profoundly influence the methodologies employed in identifying excess body fat among young individuals. He describes this as a pivotal moment in the accurate definition and diagnosis of childhood excess body fat, highlighting the potential for WHtR to be adopted as a practical, universally applicable, and clinically valuable tool. The analysis strongly suggests that the familiar rise in childhood BMI should not be automatically construed as indicative of an obesity-related process. Instead, it may signify a healthy developmental transition as children build muscle and prepare for subsequent growth phases. "Our new analysis suggests that this adiposity rebound phenomenon is not an obesity problem; this is an increase in muscle mass, and it is a good thing for healthy, normal growth. No clinical intervention is needed to address a non-existent problem in children. Let’s allow children to grow in peace," Professor Agbaje stated. To facilitate the practical application of these findings, Agbaje’s research team has developed and made freely accessible a WHtR calculator, designed to aid in the detection of excess fat in children and adolescents.
About the Author
